Concepedia

Derek Mendy

DM

Statistics

Publications

12

Citations

2.1K

H-Index

11

Active since

2008

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Derek Mendy is an author at Bristol-Myers Squibb (Switzerland) specializing in molecular oncology, medicine, and pharmacology.

ORCID

Publications per year

2008–2020

12

Publications

12

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Antonia Lopez‐Girona, Derek Mendy, Takumi Ito et al. · Leukemia · 2012 · 798 citations · Full text

, , +15

Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy

Qing Chen, Weilin Xie, Deborah J. Kuhn et al. · Blood · 2008 · 267 citations · Full text

, , +8

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

Christine Surka, Liqing Jin, Nathan Mbong et al. · Blood · 2020 · 221 citations · Full text

, , +11

Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma

Joshua D. Hansen, Matthew Correa, Mark A. Nagy et al. · Journal of Medicinal Chemistry · 2020 · 218 citations · Full text

, , +13

Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response

Antonia Lopez‐Girona, Daniel Heintel, Ling‐Hua Zhang et al. · British Journal of Haematology · 2011 · 179 citations · Full text

, , +17

1–5 of 12